Resources

Even small increases in serum creatinine levels during hospitalization raise the risk of end stage renal disease and mortality of elderly patients over the long term in a 10-year study of 87,094 patients according to a University of Alabama at Birmingham (UAB) study.

Vitamin D insufficiency is under recognized and may be a significant contributor to neuropathic pain in type 2 diabetes. Vitamin D supplementation may be an effective “analgesic” in relieving neuropathic pain.

A new study indicates that overeating, rather than the obesity it causes, is the trigger for developing metabolic syndrome, a collection of heath risk factors that increases an individual’s chances of developing insulin resistance, fatty liver, heart disease and type 2 diabetes. The study is among the first to suggest …

Early diagnosis of a heart attack may now be possible using only a few drops of saliva and a new nano-bio-chip, according to a new study.

Substances isolated from bitter melon, a plant eaten and used medicinally in much of Asia, could provide the basis of new drugs for treating diabetes and obesity, an international team of researchers reports.

A new method that uses nanotechnology to rapidly measure minute amounts of insulin is a major step toward developing the ability to assess the health of the body’s insulin-producing cells in real time.

Patients taking both a tricyclic antidepressant and a selective serotonin reuptake inhibitor (SSRI) were nearly twice as likely to develop type 2 diabetes as those taking a tricyclic antidepressant alone

Although simvastatin improves flow-mediated dilation in hypercholesterolemic patients, the drug reduces adiponectin levels and insulin sensitivity, according to a report in the April issue of Diabetes Care. These effects were not dose-dependent and also did not relate to the magnitude of apolipoprotein B reduction.

The recent report that having a pot belly in your 40s roughly triples your risk of dementia in later life is just the tip of an ominous adipose iceberg.

For type 2 diabetes with microalbuminurea, multi-drug treatment with behavior modification reduced the risk of vascular complications and death from cardiovascular and other causes by 29%.